Latest AI and machine learning research in lung cancer for healthcare professionals.
Computed tomography (CT) is essential to modern clinical practice but contributes substantially to population radiation exposure, particularly in oncology, paediatric and screening pathways. In line with the ALARP principle and IR(ME)R requirements, there is growing interest in the use of artificial intelligence (AI) to reduce dose without compromising diagnostic performance. This work synthesised...
Cytopathology, often abbreviated as cytology, has a central role in the early detection of cancer, such as cervical, lung and bladder cancers, owing to its speed, simplicity and minimally invasive nature1-9. However, its effectiveness is limited by variability in diagnostic accuracy stemming from subjective visual interpretation10-21. Although many artificial intelligence (AI)-powered systems have...
Autoantibodies (AAbs) represent promising biomarkers in cancer. While most AAbs are elevated in cancer, a substantial subset is downregulated, and the...
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the lethal malignancies, in which accurate and faster detection is required in high-risk...
BACKGROUND: The 2025 American Thyroid Association guidelines recommend total thyroidectomy for all T3b differentiated thyroid carcinoma (DTC). However...
BACKGROUND: Endocrine-disrupting chemicals (EDCs) are common environmental pollutants that affect human health. These chemicals have been linked to th...
UNLABELLED: Single-cell RNA sequencing facilitates the discovery of gene expression signatures that define cell states across patients, which could be...
Accurate lung function assessment is essential for diagnosing and managing diseases like COPD, pulmonary emboli, and lung cancer. Single-photon emissi...
Biodosimetry plays a crucial role in radiation emergency preparedness and response by enabling efficient allocation of medical resources through prior...
Deep learning-based Organ-at-Risk (OAR) and tumor segmentation is vital for radiation therapy planning but often suffers from over-parameterization, r...
PROteolysis TArgeting Chimeras (PROTACs) are bifunctional molecules that offer a novel approach to targeted protein degradation, showing particular pr...
BACKGROUND: Sarcopenia has been widely studied in rectal cancer with increasing evidence to suggest that other body composition parameters, in particu...
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive cancers, typically diagnosed at an advanced stage due to its su...
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy often diagnosed late due to the limited sensitivity and specificity of current m...
PURPOSE: Non-small cell lung carcinoma (NSCLC) is a leading cause of cancer-related mortality worldwide, highlighting the urgent need for early detect...
OBJECTIVES: To evaluate the performance of a body mass index (BMI)-based sub-milliSievert low-dose CT (LDCT) protocol with multiple reconstruction alg...
BACKGROUND: The response of resectable non-small cell lung cancer (NSCLC) to neoadjuvant immunotherapy is heterogeneous. Machine learning can integrat...
Aflatoxin B1 (AFB1), a known mycotoxin and environmental hazard, has been linked to breast cancer, yet the exact biological pathways remain poorly cha...
BACKGROUND: DNA mutations are the fundamental engines of cancer, driving its initiation and progression. The forces that fuel malignancy are also the ...